(NP (NP Glucocorticoid/NN receptors/NNS) (PP in/IN (NP systemic/JJ lupus/NN erythematosus/NN)) ./.)
(S (S-COOD (S (NP-SBJ Glucocorticosteroids/NNS) (VP remain/VBP (NP-PRD (NP the/DT major/JJ treatment/NN modality/NN) (PP for/IN (NP (NP systemic/JJ lupus/NN erythematosus/NN) (PRN -LRB-/-LRB- (NP SLE/NN) -RRB-/-RRB-)))))) ,/, but/CC (S (NP-SBJ (NP their/PRP$ mechanism/NN) (PP of/IN (NP action/NN))) (VP is/VBZ (ADJP-PRD unclear/JJ)))) ./.)
(S (PP-TMP Over/IN (NP the/DT past/JJ decade/NN)) (NP-SBJ (NP it/PRP) (SBAR *EXP*-94/-NONE-)) (VP has/VBZ (VP become/VBN (ADJP-PRD clear/JJ) (SBAR-94 that/IN (S (NP-SBJ glucocorticosteroid/NN receptors/NNS) (VP play/VBP (NP a/DT significant/JJ role/NN) (PP in/IN (NP (NP the/DT mechanism/NN) (PP of/IN (NP glucocorticosteroid/NN action/NN))))))))) ./.)
(S (NP-SBJ We/PRP) (VP studied/VBD (NP (NP glucocorticosteroid/NN receptor/NN (NP-COOD (NP density/NN) and/CC (NP affinity/NN))) (PP on/IN (NP peripheral/JJ blood/NN mononuclear/JJ cells/NNS))) (PP by/IN (NP the/DT glucocorticosteroid/NN binding/NN assay/NN)) (PP-COOD (PP in/IN (NP (NP 33/CD patients/NNS) (PP with/IN (NP SLE/NN)) (SBAR (WHNP-40 who/WP) (S (NP-SBJ *T*-40/-NONE-) (VP had/VBD (VP taken/VBN (NP no/DT glucocorticosteroid/NN) (PP-TMP for/IN (NP the/DT previous/JJ 6/CD months/NNS)))))))) and/CC (PP in/IN (NP 32/CD healthy/JJ controls/NNS)))) ./.)
(S (NP-SBJ-41 (NP Patients/NNS '/POS) disease/NN activity/NN) (VP was/VBD (VP measured/VBN (NP *-41/-NONE-) (PP by/IN (NP-LGS (NP the/DT SLE/NN Disease/NN Activity/NN Index/NN) (PRN -LRB-/-LRB- (NP SLEDAI/NN) -RRB-/-RRB-))))) ./.)
(S (NP-SBJ (NP Glucocorticosteroid/NN receptors/NNS) (PP on/IN (NP (NP leukocytes/NNS) (PP of/IN (NP (NP patients/NNS) (PP with/IN SLE/NN)))))) (VP were/VBD (ADJP-PRD (ADJP (ADJP significantly/RB higher/JJR) (PP than/IN (FRAG (PP in/IN (NP healthy/JJ controls/NNS))))) (PRN -LRB-/-LRB- (FRAG (NP-COOD (NP (QP 4419/CD +\/-/CC 306/CD)) vs/CC (NP (QP 3369/CD +\/-/CC 196/CD)))) ,/, (S (NP-SBJ p/NN) (ADJP-PRD (ADJP less/JJR) (PP than/IN (NP 0.005/CD)))) -RRB-/-RRB-))) ./.)
(S (NP-SBJ The/DT binding/NN affinity/NN) (VP was/VBD not/RB (ADJP-PRD different/JJ) (PP between/IN (NP-COOD (NP patients/NNS) and/CC (NP controls/NNS)))) ./.)
(S (NP-SBJ There/EX) (VP was/VBD (NP-PRD no/DT correlation/NN) (PP between/IN (NP-COOD (NP glucocorticosteroid/NN receptor/NN number/NN) and/CC (NP SLE/NN disease/NN activity/NN)))) ./.)
